Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
Abstract Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer (BrC) subtype lacking effective therapeutic targets currently. The development of multi-omics databases facilities the identification of core genes for TNBC. Using TCGA-BRCA and METABRIC datasets, we identified CT83 a...
Guardado en:
Autores principales: | Chen Chen, Dan Gao, Jinlong Huo, Rui Qu, Youming Guo, Xiaochi Hu, Libo Luo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b399d4aa32964048b309f22d6eb0a39d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
por: Hao Huang, et al.
Publicado: (2021) -
Integrative multiomics-histopathology analysis for breast cancer classification
por: Yasha Ektefaie, et al.
Publicado: (2021) -
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Giada Zurlo, et al.
Publicado: (2019) -
A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012) -
Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)